Now showing items 1-1 of 1

    • Thumbnail

      Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial 

      Solomón, María Teresa; Selva, Julio César; Figueredo, Javier; Vaquer, José; Toledo, Carolina; Quintanal, Nelson; Salva, Silvia; Domínguez, Rafael; Alert, José; Marinello, Jorge Juan; Catalá, Mauricio; González Griego, Martha; Martell, Juan Antonio; Lorenzo Luaces, Patricia; Ballesteros Rodríguez, Francisco Javier; De Castro, Niurys; Bach, Ferdinand; Crombet, Tania (BioMed Central, 2013-06-19)
      Background The prognosis of patients bearing high grade glioma remains dismal. Epidermal Growth Factor Receptor (EGFR) is well validated as a primary contributor of glioma initiation and progression. Nimotuzumab is a ...